CompletedNCT01050478

Paliperidone extended-release for acute agitation in psychosis

About this title

Medication studyAges 18+BelgiumSchizophrenia

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Bruges and 13 more locationsSee all locations and recruitment
Study phase: Phase 4

Study clarity

Study start dateMarch 2010

Recruitment status: Completed
Enrollment listed in the registry: 56
Sponsor: Janssen Cilag N.V./S.A.
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Drug
Study phase: Phase 4
Locations: Belgium
Age range: Over 18 Years
Official registry ID: NCT01050478
Official title: Show the full official title
Open-label, Single Arm, Interventional Study to Explore the Efficacy and Safety of Paliperidone ER in the Management of Patients With Acute Agitation and/or Aggression

Completed

Bruges · Brussels · Dave

11 more locations

FAQ

Who is behind this study?

The study sponsor is Janssen Cilag N.V./S.A.

Did this study involve medication?

Yes. The study involved medication, including Paliperidone ER and Benzodiazepine.

Who was this study for?

Listed age limits: from 18 years.